Microneedling Versus Carboxytherapy in Stria Distensae Rubra

Microneedling Versus Carboxytherapy Either With or Without Platelet Rich Plasma in Treating Stria Distensae Rubra

The aim of this study is to evaluate and compare the efficacy and safety of microneedling and carboxytherapy either with or without platelet-rich plasma in the treatment of striae distensae rubra.

Inclusion Criteria:

• Female patients.
• Age ranging from 18-45 years old.
• Fitzpatrick skin type III-IV.
• Striae distensae rubra on the abdomen (bilateral and more or less symmetrical).

Exclusion Criteria:

• Patients taking immunosuppressants or having any disease affecting wound healing including diabetes.
• Patients receiving systemic glucocorticoids for chronic health conditions.
• Patients with chronic dermatologic diseases such as psoriasis and vitiligo.
• Pregnant and lactating females.
• Patients with a tendency for keloid formation.
• Patients with endocrine disturbance.
• Patients with autoimmune diseases, systemic diseases such as severe anemia, respiratory, cardiac, renal or liver disorder.
• Patients with bleeding and coagulation disorders.
• Patients who received any form of treatment for their SD in the past 6 months.